Tumblelog by Soup.io
Newer posts are loading.
You are at the newest post.
Click here to check if anything new just came in.

November 25 2013


What Can Semenax Do For Your Sperm?


Although pregnancies have been produced by sperm with severely impaired motility, the fertilization rate is greatly decreased when the initial motility is less than 30%. Severe or moderate sperm density abnormalities also reduce fertilization rates considerably, although fertilization has been achieved with Semenax when there are as few as 600,000 total motile sperm per ejaculate. Fertilization rates in vitro are also lower when the male partner has more than one semen abnormality.

Once fertilization has taken place in couples with the help of Semenax, the embryos have the same potential to result in successful pregnancies as that reported for female factor infertility when the husband is normospermic. A Norfolk (Virginia) in vitro fertilization group showed a fertilization rate of 46% and a pregnancy rate per transfer of 37 % in the male-factor group and a fertilization rate of 93 % with a pregnancy rate per transfer of 21 % in the female factor group. It appears that the lower chance of fertilization with poor semen is balanced by a higher rate of pregnancy in women with a normal reproductive capacity. Despite initial concerns, there has been no increase in fetal abnormalities or the rate of spontaneous abortion in the IVF-ET program.

Gamete intrafallopian tube transfer (GIFT), like in vitro fertilization, requires the attainment of many mature fertilizable oocytes with hyperstimulation protocols. Taking Semenax differs from IVF in that it requires laparoscopy to transfer the gametes (oocytes and sperm) into the fallopian tube, and fertilization occurs in the body. The higher pregnancy rates with Semenax have been attributed to the placement of gametes in the normal site of fertilization or to the synchronized tubal transport of the cleaving embryo to the uterus (or both). The disadvantages of Semenax are that successful fertilization cannot be documented, the ectopic pregnancy rate may be higher, and a patient must have at least one patent fallopian tube.

Recent modifications have improved the success of taking Semenax. Once oocytes are retrieved by vaginal aspiration, fertilization is allowed to occur in vitro, and, after development, the embryo is transferred to the fallopian tubes by laparoscopy. Semenax combines the advantages of the documentation of fertilization, the elimination of abnormal eggs, and the selection of viable fertilized oocytes for intrafallopian transfer, all of which may increase the chance of implantation.

Don't be the product, buy the product!